Inhibition of interleukin-1beta reduces mouse lung inflammation induced by exposure to cigarette smoke

European Journal of Pharmacology
Paulo CastroVera Lucia Gonçalves Koatz

Abstract

We examined nuclear factor kappaB activation, release of inflammatory mediators and cellular infiltration in acute cigarette smoke inflammation models. One hour after exposure to one puff of cigarette smoke, alveolar macrophages from bronchoalveolar lavage (BAL) fluid of C57BL/6J mice showed an increased activity of nuclear factor kappaB-DNA binding but similar numbers as compared to that of BAL fluid from mice exposed to ambient air. Exposure to 1 cigarette/day for 1, 4 or 7 days led to an increase in interleukin-1beta and monocyte chemoattractant protein-1 levels and to a progressive influx of nuclear factor kappaB-activated alveolar macrophages into the BAL fluid and lung tissue. Exposure to 2 cigarettes/day for 7 days led to a significant increase in interleukin-1beta levels accompanied by a massive alveolar macrophage influx into the BAL fluid. Tumor necrosis factor-alpha levels and subsequent neutrophil influx were only detected after exposure to 4 or 8 cigarettes/day for 7 days. Treatment of mice with an antibody anti-interleukin-1beta during cigarette smoke exposure for 7 days significantly reduced both interleukin-1beta levels and alveolar macrophage influx. These data show that a single exposure to cigarette smoke rap...Continue Reading

References

Mar 1, 1992·Archives of Environmental Health·R Rylander
Apr 1, 1991·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·C B Okafor
Feb 1, 1990·The American Review of Respiratory Disease·Y Sibille, H Y Reynolds
Feb 1, 1989·Immunology Today·C A DinarelloP M Rosoff
Sep 1, 1988·Chest·P K Shah, R H Helfant
Mar 1, 1984·Physiology & Behavior·S A Wager-SrdarD E Niewoehner
Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·P N PharrG D Longmore
Sep 1, 1994·American Journal of Respiratory and Critical Care Medicine·K A McCreaJ D Hasday
Jan 1, 1996·Annual Review of Immunology·A S Baldwin
Jan 1, 1996·Free Radical Biology & Medicine·I Rahman, W MacNee
Apr 10, 1997·The New England Journal of Medicine·P J Barnes, M Karin
Jul 1, 1997·American Journal of Respiratory Cell and Molecular Biology·T S Blackwell, J W Christman
Aug 1, 1997·American Journal of Respiratory and Critical Care Medicine·J E RepineI Lankhorst
Sep 4, 1998·The European Respiratory Journal·K MatsumotoN Hara
Jan 1, 1997·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·E A RichZ Toossi
Dec 22, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·S HashimotoT Horie
Feb 5, 2000·American Journal of Respiratory Cell and Molecular Biology·R DhamiA Churg
Feb 13, 2001·Pulmonary Pharmacology & Therapeutics·P J Barnes, C Page
Feb 13, 2001·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·S HashimotoT Horie
Apr 9, 2001·Environmental Toxicology and Pharmacology·R van den BergA Bast
Sep 11, 2001·American Journal of Respiratory and Critical Care Medicine·E CavarraG Lungarella
Mar 15, 2002·Chest·George D LeikaufDaniel R Prows
Aug 23, 2002·European Journal of Pharmacology·Vivian Y ShinChi H Cho
Sep 3, 2002·American Journal of Respiratory Cell and Molecular Biology·Andrew ChurgJoanne L Wright
Oct 16, 2002·Laboratory Investigation; a Journal of Technical Methods and Pathology·Joanne L WrightAndrew Churg
Jan 11, 2003·American Journal of Respiratory and Critical Care Medicine·Andrew ChurgJoanne L Wright
Jul 10, 2004·American Journal of Respiratory Cell and Molecular Biology·Joanne L WrightAndrew Churg

❮ Previous
Next ❯

Citations

Jan 2, 2009·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Deepak K BhallaC Gary Gairola
Feb 3, 2011·Cardiovascular Research·Silvia S BarbieriElena Tremoli
Dec 8, 2009·American Journal of Physiology. Lung Cellular and Molecular Physiology·Saravanan RajendrasozhanIrfan Rahman
Mar 7, 2009·American Journal of Respiratory and Critical Care Medicine·Andreas D FlourisYiannis Koutedakis
Dec 7, 2010·American Journal of Respiratory Cell and Molecular Biology·Paul R ReynoldsJohn R Hoidal
Aug 2, 2011·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Karla Maria Pereira PiresRoberto Soares de Moura
Aug 7, 2009·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Julie St-LaurentElyse Bissonnette
Apr 15, 2010·Inhalation Toxicology·Laurent SchwartzAbolhassani Mohammad
Aug 8, 2007·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Chang-Hsien LeeTin-Yun Ho
Jan 24, 2009·Biochemical Pharmacology·Paulo CastroVera Lucia G Koatz
Jun 13, 2013·Diabetes Care·Martin LajousFrançoise Clavel-Chapelon
Feb 11, 2015·Pulmonary Pharmacology & Therapeutics·Paola RoglianiMaria Gabriella Matera
Aug 8, 2013·Cellular Immunology·Keila Karine Duarte CamposFrank Silva Bezerra
Mar 3, 2017·Inflammation·Vanessa Pinho-RibeiroSamuel Santos Valença
Sep 13, 2006·International Journal of Experimental Pathology·Samuel Santos ValencaLuís Cristóvão Porto
Mar 13, 2019·Basic & Clinical Pharmacology & Toxicology·I-Ling ChenLucy C Fairclough
Jan 13, 2009·American Journal of Physiology. Lung Cellular and Molecular Physiology·Mohammad AbolhassaniLaurent Schwartz
Apr 17, 2012·American Journal of Physiology. Lung Cellular and Molecular Physiology·Adam B RobinsonPaul R Reynolds
Dec 13, 2007·American Journal of Physiology. Endocrinology and Metabolism·Andreas D FlourisYiannis Koutedakis
Jul 7, 2007·Physiological Reviews·Toshinori Yoshida, Rubin M Tuder
Feb 24, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Silvia S Barbieri, Babette B Weksler
Jul 9, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Silvia S BarbieriElena Tremoli
Sep 5, 2020·Artificial Cells, Nanomedicine, and Biotechnology·Min QiuQuanli Liu
Mar 23, 2018·Scientific Reports·Máira Tereza Talma ChíricoRodrigo Cunha de Menezes
Jan 8, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Emilie DozIsabelle Couillin
Apr 1, 2008·American Journal of Physiology. Lung Cellular and Molecular Physiology·Hongwei YaoIrfan Rahman
Jul 28, 2020·Brain, Behavior, and Immunity·Yanlong LiuFan Wang
Jun 1, 2007·Toxicon : Official Journal of the International Society on Toxinology·André L FulyVera Lucia G Koatz
Sep 10, 2017·Bioorganic & Medicinal Chemistry·Marina Valente BarrosoManuella Lanzetti
Aug 28, 2007·Clinics in Chest Medicine·William Macnee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.